R&D intensity, Growth and Financial Performance in Indian Drug & Pharmaceuticals firms

被引:0
作者
Shetty, Snehal [1 ]
Sundaram, Ranjany [1 ]
机构
[1] Amrita Vishwa Vidyapeetham, Kollam, India
来源
VISION 2020: SUSTAINABLE ECONOMIC DEVELOPMENT AND APPLICATION OF INNOVATION MANAGEMENT | 2018年
关键词
R&D Intensity; Drug & Pharmaceuticals; export intensity; Indian firms; RESOURCES;
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper studies the various factors that influence the R&D intensity in firms and the influence of each of these factors. It analyses if the financial slack, leverage and other financial factors impact the R&D outlay and the associated R&D intensity of these firms. Also, studied are the impacts of R&D intensity on the future performance of the firms in terms of sales, employment generated, profit margin etc. For this study, we have focused on the Drug and Pharmaceutical industry where R&D is a major competitive factor and firms specifically focus on R&D to create differentiation. We found that financial slack enabled higher R&D intensities which led to better revenue growth and employment in the following year but this effect progressively decreased over time.
引用
收藏
页码:4145 / 4156
页数:12
相关论文
共 31 条
[1]  
Andras T., 2003, ADVERTISING INTENSIT
[2]   FIRM RESOURCES AND SUSTAINED COMPETITIVE ADVANTAGE [J].
BARNEY, J .
JOURNAL OF MANAGEMENT, 1991, 17 (01) :99-120
[3]  
Bourgeois L. J., 1981, The Academy of Management Review, V6, P29, DOI [10.2307/257138, DOI 10.2307/257138, DOI 10.5465/AMR.1981.4287985]
[4]  
Brenner M., 1989, SALES GROWTH R D CHE
[5]  
Chambers D., 2002, EXCESS RETURNS R D I
[6]  
Cyert R.M., 1963, BEHAV THEORY FIRM, V1
[7]  
Damanpour F., 1991, ORG INNOVATION METAA
[8]  
Ettlie J., 1998, R D GLOBAL MANUFACTU
[9]  
Falk M., 2010, QUANTILE ESTIMATES I
[10]  
George G, 2005, ACAD MANAGE J, V48, P661, DOI 10.2307/20159685